{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:16:38Z","timestamp":1737436598867,"version":"3.33.0"},"posted":{"date-parts":[[2024,10,15]]},"group-title":"In Review","reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,8,7]]},"abstract":"<title>Abstract<\/title>\n        <p>Purpose\n Treatment of pediatric cancers with doxorubicin is a common and predictable cause of cardiomyopathy. Early diagnosis of treatment-induced cardiotoxicity and intervention are major determinants for the prevention of advanced disease. The onset of cardiomyopathies is often accompanied by profound changes in lipid metabolism, including an enhanced uptake of short-chain fatty acids (SCFA). Therefore, we explored the utility of 2-[<sup>18<\/sup>F]fluoropropionic acid ([<sup>18<\/sup>F]FPA), an SCFA analog, as an imaging biomarker of cardiac injury in mice exposed to doxorubicin. <italic>Procedures<\/italic>: Cardiotoxicity and cardiac dysfunction were induced in mice by an 8-dose regimen of doxorubicin (cumulative dose 24 mg\/kg) administered over 14 days. The effects of doxorubicin exposure were assessed by measurement of heart weights, left ventricular ejection fractions, and blood cardiac troponin levels. Whole body and cardiac [<sup>18<\/sup>F]FPA uptakes were determined by PET and tissue gamma counting in the presence or absence of AZD3965, a pharmacological inhibitor of monocarboxylate transporter 1 (MCT1). Radiation absorbed doses were estimated using tissue time-activity concentrations.\nResults\n Significantly higher cardiac [<sup>18<\/sup>F]FPA uptake was observed in doxorubicin-treated animals. This uptake remained constant from 30 min to 120 min post-injection. Pharmacological inhibition of MCT1-mediated transport by AZD3965 selectively decreased the uptake of [<sup>18<\/sup>F]FPA in tissues other than the heart. Co-administration of [<sup>18<\/sup>F]FPA and AZD3965 enhanced the imaging contrast of the diseased heart while reducing overall exposure to radioactivity.\nConclusions\n [<sup>18<\/sup>F]FPA, especially when co-administered with AZD3965, is a new tool for imaging changes in fatty acid metabolism occurring in response to doxorubicin-induced cardiomyopathy by PET.<\/p>","DOI":"10.21203\/rs.3.rs-4876095\/v1","type":"posted-content","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T08:44:50Z","timestamp":1728981890000},"source":"Crossref","is-referenced-by-count":0,"title":["2-[18F]Fluoropropionic Acid PET Imaging of Doxorubicin-induced Cardiotoxicity"],"prefix":"10.21203","author":[{"given":"Juan A.","family":"Azcona","sequence":"first","affiliation":[{"name":"Weill Cornell Medical College: Weill Cornell Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja S.","family":"Wacker","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College: Weill Cornell Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Hee","family":"Lee","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College: Weill Cornell Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward K.","family":"Fung","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College: Weill Cornell Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Jeitner","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College: Weill Cornell Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onorina L.","family":"Manzo","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College: Weill Cornell Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarita Di","family":"Lorenzo","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College: Weill Cornell Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Babich","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College: Weill Cornell Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Amor-Coarasa","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-0047","authenticated-orcid":false,"given":"James M.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College: Weill Cornell Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"8","key":"ref1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann J","year":"2020","unstructured":"Herrmann J (2020) Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol 17(8):474\u2013502. 10.1038\/s41569-020-0348-1","journal-title":"Nat Rev Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3579143","DOI":"10.1155\/2020\/3579143","article-title":"Oxidative Stress in Radiation-Induced Cardiotoxicity","author":"Ping Z","year":"2020","unstructured":"Ping Z, Peng Y, Lang H et al (2020) Oxidative Stress in Radiation-Induced Cardiotoxicity. Oxid Med Cell Longev 3579143. 10.1155\/2020\/3579143","journal-title":"Oxid Med Cell Longev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-030-43032-0_15","article-title":"Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention","volume":"1257","author":"Bhagat A","year":"2020","unstructured":"Bhagat A, Kleinerman ES (2020) Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention. Adv Exp Med Biol 1257:181\u2013192. 10.1007\/978-3-030-43032-0_15","journal-title":"Adv Exp Med Biol"},{"issue":"2\u20133","key":"ref4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/J.TOX.2010.01.019","article-title":"Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy","volume":"270","author":"Carvalho RA","year":"2010","unstructured":"Carvalho RA, Sousa RPB, Cadete VJJ et al (2010) Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy. Toxicology 270(2\u20133):92\u201398. 10.1016\/J.TOX.2010.01.019","journal-title":"Toxicology"},{"issue":"3","key":"ref5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/HC0302.102594","article-title":"Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction","volume":"105","author":"Lewandowski ED","year":"2002","unstructured":"Lewandowski ED, Kudej RK, White LT, O\u2019Donnell JM, Vatner SF (2002) Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction. Circulation 105(3):367\u2013372. 10.1161\/HC0302.102594","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1161\/CIRCULATIONAHA.120.052671","article-title":"Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart","volume":"143","author":"Carley AN","year":"2021","unstructured":"Carley AN, Maurya SK, Fasano M et al (2021) Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart. Circulation 143:1797\u20131808. 10.1161\/CIRCULATIONAHA.120.052671","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"915102","DOI":"10.3389\/FCVM.2022.915102","article-title":"Short-Chain Fatty Acids in the Metabolism of Heart Failure \u2013 Rethinking the Fat Stigma","volume":"9","author":"Palm CL","year":"2022","unstructured":"Palm CL, Nijholt KT, Bakker BM, Westenbrink BD (2022) Short-Chain Fatty Acids in the Metabolism of Heart Failure \u2013 Rethinking the Fat Stigma. Front Cardiovasc Med 9:915102. 10.3389\/FCVM.2022.915102","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"ref8","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2967\/JNUMED.109.064212","article-title":"2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer","volume":"50","author":"Pillarsetty NVK","year":"2009","unstructured":"Pillarsetty NVK, Punzalan B, Larson SM (2009) 2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer. J Nucl Med 50(10):1709\u20131714. 10.2967\/JNUMED.109.064212","journal-title":"J Nucl Med"},{"issue":"6","key":"ref9","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/S11307-019-01346-1","article-title":"Validation of R-2-[ 18 F]Fluoropropionic Acid as a Potential Tracer for PET Imaging of Liver Cancer","volume":"21","author":"Zhang Z","year":"2019","unstructured":"Zhang Z, Liu S, Ma H et al (2019) Validation of R-2-[ 18 F]Fluoropropionic Acid as a Potential Tracer for PET Imaging of Liver Cancer. Mol imaging Biol 21(6):1127\u20131137. 10.1007\/S11307-019-01346-1","journal-title":"Mol imaging Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1536012118821032","article-title":"PET Imaging of Hepatocellular Carcinomas: 18 F-Fluoropropionic Acid as a Complementary Radiotracer for 18 F-Fluorodeoxyglucose","volume":"18","author":"Zhao J","year":"2019","unstructured":"Zhao J, Zhang Z, Nie D et al (2019) PET Imaging of Hepatocellular Carcinomas: 18 F-Fluoropropionic Acid as a Complementary Radiotracer for 18 F-Fluorodeoxyglucose. Mol Imaging 18. 10.1177\/1536012118821032","journal-title":"Mol Imaging"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/S10967-018-5753-0","article-title":"Radiosynthesis and preliminary biological evaluation of the 2-[18F]fluoropropionic acid enantiomers for tumor PET imaging","volume":"316","author":"Zhang Z","year":"2018","unstructured":"Zhang Z, Liu S, Tang X et al (2018) Radiosynthesis and preliminary biological evaluation of the 2-[18F]fluoropropionic acid enantiomers for tumor PET imaging. J Radioanal Nucl Chem 316(1):153\u2013159. 10.1007\/S10967-018-5753-0","journal-title":"J Radioanal Nucl Chem"},{"issue":"6","key":"ref12","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/S11307-021-01608-X","article-title":"Propionic Acid-Based PET Imaging of Prostate Cancer","volume":"23","author":"Zhang Z","year":"2021","unstructured":"Zhang Z, Liu S, Ma H et al (2021) Propionic Acid-Based PET Imaging of Prostate Cancer. Mol Imaging Biol 23(6):836\u2013845. 10.1007\/S11307-021-01608-X","journal-title":"Mol Imaging Biol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"216329","DOI":"10.1016\/J.CANLET.2023.216329","article-title":"Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma","volume":"570","author":"Martino M","year":"2023","unstructured":"De Martino M, Daviaud C, Minns HE et al (2023) Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma. Cancer Lett 570:216329. 10.1016\/J.CANLET.2023.216329","journal-title":"Cancer Lett"},{"issue":"1","key":"ref14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2967\/JNMT.113.132621","article-title":"18F-FDG PET and PET\/CT Patient Preparation: A Review of the Literature","volume":"42","author":"Surasi DS","year":"2014","unstructured":"Surasi DS, Bhambhvani P, Baldwin JA, Almodovar SE, O\u2019Malley JP (2014) 18F-FDG PET and PET\/CT Patient Preparation: A Review of the Literature. J Nucl Med Technol 42(1):5\u201313. 10.2967\/JNMT.113.132621","journal-title":"J Nucl Med Technol"},{"issue":"3","key":"ref15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.plefa.2006.05.003","article-title":"How fatty acids of different chain length enter and leave cells by free diffusion","volume":"75","author":"Kamp F","year":"2006","unstructured":"Kamp F, Hamilton JA (2006) How fatty acids of different chain length enter and leave cells by free diffusion. Prostaglandins Leukot Essent Fat Acids 75(3):149\u2013159. 10.1016\/j.plefa.2006.05.003","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"Pt 2","key":"ref16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1113\/JPHYSIOL.2006.115931","article-title":"Monocarboxylate transporter 1 (MCT1) plays a direct role in short-chain fatty acids absorption in caprine rumen","volume":"576","author":"Kirat D","year":"2006","unstructured":"Kirat D, Masuoka J, Hayashi H et al (2006) Monocarboxylate transporter 1 (MCT1) plays a direct role in short-chain fatty acids absorption in caprine rumen. J Physiol 576(Pt 2):635. 10.1113\/JPHYSIOL.2006.115931","journal-title":"J Physiol"},{"issue":"4","key":"ref17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2967\/JNUMED.119.233288","article-title":"Human Radiation Dosimetry for Orally and Intravenously Administered 18F-FDG","volume":"61","author":"Srinivasan S","year":"2020","unstructured":"Srinivasan S, Crandall JP, Gajwani P et al (2020) Human Radiation Dosimetry for Orally and Intravenously Administered 18F-FDG. J Nucl Med 61(4):613\u2013619. 10.2967\/JNUMED.119.233288","journal-title":"J Nucl Med"},{"issue":"1","key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13550-018-0462-9\/FIGURES\/4","article-title":"First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68 Ga-NODAGA-MJ9","volume":"8","author":"Gnesin S","year":"2018","unstructured":"Gnesin S, Cicone F, Mitsakis P et al (2018) First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68 Ga-NODAGA-MJ9. EJNMMI Res 8(1):1\u201310. 10.1186\/S13550-018-0462-9\/FIGURES\/4","journal-title":"EJNMMI Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.IJCHA.2015.11.004","article-title":"Doxorubicin induced heart failure: Phenotype and molecular mechanisms","volume":"10","author":"Mitry MA","year":"2016","unstructured":"Mitry MA, Edwards JG (2016) Doxorubicin induced heart failure: Phenotype and molecular mechanisms. IJC Hear Vasc 10:17\u201324. 10.1016\/J.IJCHA.2015.11.004","journal-title":"IJC Hear Vasc"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"670479","DOI":"10.3389\/FPHAR.2021.670479\/FULL","article-title":"Analysis of models of doxorubicin-induced cardiomyopathy in rats and mice. A modern view from the perspective of the pathophysiologist and the clinician","volume":"12","author":"Podyacheva EY","year":"2021","unstructured":"Podyacheva EY, Kushnareva EA, Karpov AA, Toropova YG (2021) Analysis of models of doxorubicin-induced cardiomyopathy in rats and mice. A modern view from the perspective of the pathophysiologist and the clinician. Front Pharmacol 12:670479. 10.3389\/FPHAR.2021.670479\/FULL","journal-title":"Front Pharmacol"},{"issue":"2","key":"ref21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0021-9258(19)50835-3","article-title":"The acetate activating enzyme of beef heart","volume":"206","author":"Hele P","year":"1954","unstructured":"Hele P (1954) The acetate activating enzyme of beef heart. J Biol Chem 206(2):671\u2013676. 10.1016\/S0021-9258(19)50835-3","journal-title":"J Biol Chem"},{"issue":"1","key":"ref22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0005-2760(75)90040-5","article-title":"The activation of short-chain fatty acids by the soluble fraction of guinea-pig heart and liver mitochondria. The search for a distinct propionyl-CoA synthetase","volume":"380","author":"Groot PH","year":"1975","unstructured":"Groot PH (1975) The activation of short-chain fatty acids by the soluble fraction of guinea-pig heart and liver mitochondria. The search for a distinct propionyl-CoA synthetase. Biochim Biophys Acta 380(1):12\u201320. 10.1016\/0005-2760(75)90040-5","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/S00395-012-0273-5","article-title":"Emerging beneficial roles of sirtuins in heart failure","volume":"107","author":"Tanno M","year":"2012","unstructured":"Tanno M, Kuno A, Horio Y, Miura T (2012) Emerging beneficial roles of sirtuins in heart failure. Basic Res Cardiol 107(4). 10.1007\/S00395-012-0273-5","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"ref24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.YGENO.2009.03.003","article-title":"Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy","volume":"94","author":"Colak D","year":"2009","unstructured":"Colak D, Kaya N, Al-Zahrani J et al (2009) Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy. Genomics 94(1):20. 10.1016\/J.YGENO.2009.03.003","journal-title":"Genomics"},{"issue":"5","key":"ref25","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1007\/S12350-018-1458-6","article-title":"Rubidium-82 positron emission tomography for detection of acute doxorubicin-induced cardiac effects in lymphoma patients","volume":"27","author":"Laursen AH","year":"2020","unstructured":"Laursen AH, Elming MB, Ripa RS et al (2020) Rubidium-82 positron emission tomography for detection of acute doxorubicin-induced cardiac effects in lymphoma patients. J Nucl Cardiol 27(5):1698\u20131707. 10.1007\/S12350-018-1458-6","journal-title":"J Nucl Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/J.CLINIMAG.2020.07.026","article-title":"A pilot study of 13N-ammonia cardiac PET imaging to assess subacute cardiotoxicity following adjuvant intensity-modulated radiotherapy for locally advanced breast cancer","volume":"68","author":"Nehmeh SA","year":"2020","unstructured":"Nehmeh SA, Fox JJ, Schwartz J et al (2020) A pilot study of 13N-ammonia cardiac PET imaging to assess subacute cardiotoxicity following adjuvant intensity-modulated radiotherapy for locally advanced breast cancer. Clin Imaging 68:283\u2013290. 10.1016\/J.CLINIMAG.2020.07.026","journal-title":"Clin Imaging"},{"issue":"2","key":"ref27","doi-asserted-by":"publisher","first-page":"E014419","DOI":"10.1161\/CIRCIMAGING.122.014419","article-title":"Myocardial Work in Echocardiography","volume":"16","author":"Marzlin N","year":"2023","unstructured":"Marzlin N, Hays AG, Peters M et al (2023) Myocardial Work in Echocardiography. Circ Cardiovasc Imaging 16(2):E014419. 10.1161\/CIRCIMAGING.122.014419","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/J.EJMP.2020.01.008","article-title":"Ultrasound-driven cardiac MRI","volume":"70","author":"Santini F","year":"2020","unstructured":"Santini F, Gui L, Lorton O et al (2020) Ultrasound-driven cardiac MRI. Phys Med 70:161\u2013168. 10.1016\/J.EJMP.2020.01.008","journal-title":"Phys Med"},{"issue":"1","key":"ref29","first-page":"55","article-title":"An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure","volume":"42","author":"Taylor M","year":"2001","unstructured":"Taylor M, Wallhaus TR, Degrado TR et al (2001) An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. J Nucl Med 42(1):55\u201362","journal-title":"J Nucl Med"},{"issue":"12","key":"ref30","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00259-002-0979-y","article-title":"14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle","volume":"29","author":"Takala TO","year":"2002","unstructured":"Takala TO, Nuutila P, Pulkki K et al (2002) 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle. Eur J Nucl Med 29(12):1617\u20131622. 10.1007\/s00259-002-0979-y","journal-title":"Eur J Nucl Med"},{"issue":"4","key":"ref31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/01.CIR.80.4.863","article-title":"Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography","volume":"80","author":"Armbrecht JJ","year":"1989","unstructured":"Armbrecht JJ, Buxton DB, Brunken RC, Phelps ME, Schelbert HR (1989) Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. Circulation 80(4):863\u2013872. 10.1161\/01.CIR.80.4.863","journal-title":"Circulation"},{"issue":"12","key":"ref32","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.2967\/JNUMED.107.044503","article-title":"L-3-11C-lactate as a PET tracer of myocardial lactate metabolism: a feasibility study","volume":"48","author":"Herrero P","year":"2007","unstructured":"Herrero P, Dence CS, Coggan AR, Kisrieva-Ware Z, Eisenbeis P, Gropler RJ (2007) L-3-11C-lactate as a PET tracer of myocardial lactate metabolism: a feasibility study. J Nucl Med 48(12):2046\u20132055. 10.2967\/JNUMED.107.044503","journal-title":"J Nucl Med"},{"issue":"3","key":"ref33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/S11886-022-01641-4","article-title":"PET Tracers for Imaging Cardiac Function in Cardio-oncology","volume":"24","author":"Kelly JM","year":"2022","unstructured":"Kelly JM, Babich JW (2022) PET Tracers for Imaging Cardiac Function in Cardio-oncology. Curr Cardiol Rep 24(3):247. 10.1007\/S11886-022-01641-4","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"ref34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/01.CIR.55.6.853","article-title":"Detection of remote myocardial infarction in patients with positron emission transaxial tomography and intravenous 11C-palmitate","volume":"55","author":"Sobel BE","year":"1977","unstructured":"Sobel BE, Weiss ES, Welch MJ, Siegel BA, Ter-Pogossian MM (1977) Detection of remote myocardial infarction in patients with positron emission transaxial tomography and intravenous 11C-palmitate. Circulation 55(6):853\u2013857. 10.1161\/01.CIR.55.6.853","journal-title":"Circulation"},{"issue":"5","key":"ref35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/J.CARPATH.2011.11.007","article-title":"The pathophysiology of heart failure","volume":"21","author":"Kemp CD","year":"2012","unstructured":"Kemp CD, Conte JV (2012) The pathophysiology of heart failure. Cardiovasc Pathol 21(5):365\u2013371. 10.1016\/J.CARPATH.2011.11.007","journal-title":"Cardiovasc Pathol"},{"issue":"6","key":"ref36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac Metabolism in Heart Failure","volume":"113","author":"Doenst T","year":"2013","unstructured":"Doenst T, Nguyen TD, Abel ED (2013) Cardiac Metabolism in Heart Failure. Circ Res 113(6):709\u2013724. 10.1161\/CIRCRESAHA.113.300376","journal-title":"Circ Res"},{"issue":"1122","key":"ref37","doi-asserted-by":"publisher","DOI":"10.1259\/BJR.20201204","article-title":"Infection imaging using [18F]FDG-labelled white blood cell positron emission tomography\u2013computed tomography","volume":"94","author":"Krishnaraju VS","year":"2021","unstructured":"Krishnaraju VS, Singh H, Kumar R, Sharma S, Mittal BR, Bhattacharya A (2021) Infection imaging using [18F]FDG-labelled white blood cell positron emission tomography\u2013computed tomography. Br J Radiol 94(1122). 10.1259\/BJR.20201204","journal-title":"Br J Radiol"},{"issue":"11","key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S12410-019-9517-1\/FIGURES\/3","article-title":"FDG-PET Imaging of Doxorubicin-Induced Cardiotoxicity: a New Window on an Old Problem","volume":"12","author":"Bauckneht M","year":"2019","unstructured":"Bauckneht M, Cossu V, Miceli A et al (2019) FDG-PET Imaging of Doxorubicin-Induced Cardiotoxicity: a New Window on an Old Problem. Curr Cardiovasc Imaging Rep 12(11):1\u20138. 10.1007\/S12410-019-9517-1\/FIGURES\/3","journal-title":"Curr Cardiovasc Imaging Rep"},{"issue":"10","key":"ref39","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/GUT.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings JH","year":"1987","unstructured":"Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28(10):1221\u20131227. 10.1136\/GUT.28.10.1221","journal-title":"Gut"},{"issue":"7","key":"ref40","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1097\/RLU.0000000000001063","article-title":"Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis","volume":"41","author":"Tang R","year":"2016","unstructured":"Tang R, Wang JTY, Wang L et al (2016) Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis. Clin Nucl Med 41(7):e327\u2013e339. 10.1097\/RLU.0000000000001063","journal-title":"Clin Nucl Med"},{"issue":"12","key":"ref41","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1158\/1535-7163.MCT-13-1091","article-title":"Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport","volume":"13","author":"Bola BM","year":"2014","unstructured":"Bola BM, Chadwick AL, Michopoulos F et al (2014) Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport. Mol Cancer Ther 13(12):2805\u20132816. 10.1158\/1535-7163.MCT-13-1091","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"ref42","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A Phase I Dose-Escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer","volume":"29","author":"Halford S","year":"2023","unstructured":"Halford S, Veal GJ, Wedge SR et al (2023) A Phase I Dose-Escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer. Clin Cancer Res 29(8):1429\u20131439. 10.1158\/1078-0432.CCR-22-2263","journal-title":"Clin Cancer Res"},{"issue":"3","key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CANCERS13030569","article-title":"In Vitro and In Vivo Characterization of MCT1 Inhibitor AZD3965 Confirms Preclinical Safety Compatible with Breast Cancer Treatment","volume":"13","author":"Benyahia Z","year":"2021","unstructured":"Benyahia Z, Blackman MCNM, Hamelin L et al (2021) In Vitro and In Vivo Characterization of MCT1 Inhibitor AZD3965 Confirms Preclinical Safety Compatible with Breast Cancer Treatment. Cancers (Basel) 13(3):1\u201325. 10.3390\/CANCERS13030569","journal-title":"Cancers (Basel)"},{"issue":"1","key":"ref44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11095-019-2735-Z\/TABLES\/3","article-title":"Pharmacokinetics of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Mice: Potential Enterohepatic Circulation and Target-Mediated Disposition","volume":"37","author":"Guan X","year":"2020","unstructured":"Guan X, Morris ME (2020) Pharmacokinetics of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Mice: Potential Enterohepatic Circulation and Target-Mediated Disposition. Pharm Res 37(1):1\u201313. 10.1007\/S11095-019-2735-Z\/TABLES\/3","journal-title":"Pharm Res"},{"issue":"9","key":"ref45","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/JLR.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"Den Besten G","year":"2013","unstructured":"Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BB (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325\u20132340. 10.1194\/JLR.R036012","journal-title":"J Lipid Res"},{"issue":"22","key":"ref46","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","article-title":"Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage","volume":"76","author":"Wang L","year":"2016","unstructured":"Wang L, Chen Q, Qi H et al (2016) Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage. Cancer Res 76(22):6631\u20136642. 10.1158\/0008-5472.CAN-15-3034","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"ref47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/A:1014806723147","article-title":"Immunogold cytochemistry identifies specialized membrane domains for monocarboxylate transport in the central nervous system","volume":"27","author":"Bergersen L","year":"2002","unstructured":"Bergersen L, Rafiki A, Ottersen OP (2002) Immunogold cytochemistry identifies specialized membrane domains for monocarboxylate transport in the central nervous system. Neurochem Res 27(1\u20132):89\u201396. 10.1023\/A:1014806723147","journal-title":"Neurochem Res"},{"issue":"3","key":"ref48","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0306-4522(00)00294-3","article-title":"Cell-specific localization of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double immunohistochemical labeling and confocal microscopy","volume":"100","author":"Pierre K","year":"2000","unstructured":"Pierre K, Pellerin L, Debernardi R, Riederer BM, Magistretti PJ (2000) Cell-specific localization of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double immunohistochemical labeling and confocal microscopy. Neuroscience 100(3):617\u2013627. 10.1016\/S0306-4522(00)00294-3","journal-title":"Neuroscience"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBR.2019.112233","article-title":"Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration","volume":"378","author":"Cardoso CV","year":"2020","unstructured":"Cardoso CV, de Barros MP, Bachi AL et al (2020) Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration. Behav Brain Res 378. 10.1016\/J.BBR.2019.112233","journal-title":"Behav Brain Res"},{"issue":"5","key":"ref50","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/01.CIR.0000023531.22727.C1","article-title":"Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-\u03b1 in pacing-induced heart failure","volume":"106","author":"Osorio JC","year":"2002","unstructured":"Osorio JC, Stanley WC, Linke A et al (2002) Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-\u03b1 in pacing-induced heart failure. Circulation 106(5):606\u2013612. 10.1161\/01.CIR.0000023531.22727.C1","journal-title":"Circulation"},{"issue":"3","key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/PH16030391","article-title":"Exposure to Doxorubicin Modulates the Cardiac Response to Isoproterenol in Male and Female Mice","volume":"16","author":"Agostinucci K","year":"2023","unstructured":"Agostinucci K, Grant MKO, Melaku W, Nair C, Zordoky BN (2023) Exposure to Doxorubicin Modulates the Cardiac Response to Isoproterenol in Male and Female Mice. Pharmaceuticals 16(3). 10.3390\/PH16030391","journal-title":"Pharmaceuticals"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4876095\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4876095\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T16:07:25Z","timestamp":1737389245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4876095\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":51,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4876095\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s11307-024-01978-y","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,10,15]]},"subtype":"preprint"}}